Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Julie C. Søholm
  • Marianne Vestgaard
  • Björg Ásbjörnsdóttir
  • Nicoline C. Do
  • Berit W. Pedersen
  • Lone Storgaard
  • Birgitte B. Nielsen
  • Lene Ringholm
  • Damm, Peter
  • Mathiesen, Elisabeth

Aims/hypothesis: We aimed to identify potentially modifiable risk factors and causes for preterm delivery in women with type 1 or type 2 (pre-existing) diabetes. Methods: A secondary analysis of a prospective cohort study of 203 women with pre-existing diabetes (117 type 1 and 86 type 2 diabetes) was performed. Consecutive singleton pregnancies were included at the first antenatal visit between September 2015 and February 2018. Results: In total, 27% (n = 55) of the 203 women delivered preterm at median 36 + 0 weeks. When stratified by diabetes type, 33% of women with type 1 diabetes delivered preterm compared with 20% in women with type 2 diabetes (p = 0.04). Women delivering preterm were characterised by a higher prevalence of pre-existing kidney involvement (microalbuminuria or diabetic nephropathy) (16% vs 3%, p = 0.002), preeclampsia (26% vs 5%, p < 0.001), higher positive ultrasound estimated fetal weight deviation at 27 gestational weeks (2.7% vs −1.6% from the mean, p = 0.008), higher gestational weight gain (399 g/week vs 329 g/week, p = 0.01) and similar HbA1c levels in early pregnancy (51 mmol/mol [6.8%] vs 49 [6.6%], p = 0.22) when compared with women delivering at term. Independent risk factors for preterm delivery were pre-existing kidney involvement (OR 12.71 [95% CI 3.0, 53.79]), higher gestational weight gain (per 100 g/week, OR 1.25 [1.02, 1.54]), higher positive ultrasound estimated fetal weight deviation at 27 gestational weeks (% from the mean, OR 1.07 [1.03, 1.12]) and preeclampsia (OR 7.04 [2.34, 21.19]). Two-thirds of preterm deliveries were indicated and one-third were spontaneous. Several contributing factors to indicated preterm delivery were often present in each woman. The main indications were suspected fetal asphyxia (45%), hypertensive disorders (34%), fetal overgrowth (13%) and maternal indications (8%). Suspected fetal asphyxia mainly included falling insulin requirement and abnormal fetal haemodynamics. Conclusions/interpretations: Presence of preeclampsia, higher positive ultrasound estimated fetal weight deviation at 27 gestational weeks and higher gestational weight gain were independent potentially modifiable risk factors for preterm delivery in this cohort of women with pre-existing diabetes. Indicated preterm delivery was common with suspected fetal asphyxia or preeclampsia as the most prevalent causes. Prospective studies evaluating whether modifying these predictors will reduce the prevalence of preterm delivery are warranted. Graphical abstract: [Figure not available: see fulltext.].

OriginalsprogEngelsk
TidsskriftDiabetologia
Vol/bind64
Sider (fra-til)1939–1948
ISSN0012-186X
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
ERM has received fees for giving talks for Novo Nordisk A/S. PD, LR and ERM are participating in multicentre and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. LR has received a grant from Novo Nordisk (Grant no. U1111-1209-6358) for another investigator lead study which include some part-time salary to ERM and LR. JCS, MV, BA, NCD, BWP, LS and BBN declare that there are no relationships or activities that might bias, or be perceived to bias, their work.

Funding Information:
MV was funded by Rigshospitalet’s Research Foundation. NCD, BA and ERM were funded by Novo Nordisk Foundation (grant no. NNF14OC0009275).

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

ID: 273649017